Different Expressions of HIF-, Bcl-2 and Baxin DU145 Prostate Cancer Cells Transplanted in Nude Mouse between X-Ray and Neutron Irradiation |
Kong, Moon-Kyoo
(Departments of Radiation Oncology, Kyung Hee University School of Medicine)
Kang, Jin-Oh (Departments of Radiation Oncology, Kyung Hee University School of Medicine) Kim, Sang-Ki (Departments of Radiation Oncology, Kyung Hee University School of Medicine) Shin, Dong-Oh (Departments of Radiation Oncology, Kyung Hee University School of Medicine) Park, Seo-Hyun (Departments of Radiation Oncology, Kyung Hee University School of Medicine) Kim, Chang-Ju (Departments of Physiology, Kyung Hee University School of Medicine) Chang, Hyun-Kyung (Departments of Physiology, Kyung Hee University School of Medicine) |
1 | Halperin EC. Particle therapy and treatment of cancer. Lancet Oncol 2006;7:676-685 DOI PUBMED ScienceOn |
2 | Vral A, Cornelissen M, Thierens H, et al. Apoptosis induced by fast neutrons versus 60Co gamma-rays in human peripheral blood lymphocytes. Int J Radiat Biol 1998;73:289-295 DOI ScienceOn |
3 | Meijer AE, Kronqvist US, Lewensohn R, Harms-Ringdahl M. RBE for the induction of apoptosis in human peripheral lymphocytes exposed in vitro to high-LET radiation generated by accelerated nitrogen ions. Int J Radiat Biol 1998;73:169-177 DOI ScienceOn |
4 | Kyprianou N, King ED, Bradbury D, Rhee JG. Bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells. Int J Cancer 1997;70:341-348 DOI ScienceOn |
5 | Szostak MJ, Kaur P, Amin P, Jacobs SC, Kyprianou N. Apoptosis and bcl-2 expression in prostate cancer: significance in clinical outcome after brachytherapy. J Urol 2001;165:2126-2130 DOI PUBMED ScienceOn |
6 | Mu Z, Hachem P, Pollack A. Antisense Bcl-2 sensitizes prostate cancer cells to radiation. Prostate 2005;65:331-340 DOI ScienceOn |
7 | Russell KJ, Caplan RJ, Laramore GE, et al. Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial. Int J Radiat Oncol Biol Phys 1994;28:47-54 DOI PUBMED ScienceOn |
8 | Piret JP, Mottet D, Raes M, Michiels C. Is HIF-1alpha a pro- or an anti-apoptotic protein? Biochem Pharmacol 2002;64:889-892 DOI PUBMED ScienceOn |
9 | Eom KY, Wu HG, Park HJ, et al. Evaluation of biological characteristics of neutron beam generated from MC50 cyclotron. J Korean Soc Ther Radiol Oncol 2006;24:280-284 |
10 | Lee HJ, Kim JS, Moon C, Kim JC, Jo SK, Kim SH. Relative biological effectiveness of fast neutrons in a multiorgan assay for apoptosis in mouse. Environ Toxicol 2008;23:233-239 DOI ScienceOn |
11 | Strowbridge A, Wall N, Aref A, et al. Neutron radiation induces the modulation of BCL-2 and BAX protein resulting in apoptosis in a chemotherapy resistant intermediate grade non-Hodgkin's lymphoma cell line. Proc Am Soc Clin Oncol 2000;19:abstr 2601 |
12 | Moeller BJ, Richardson RA, Dewhirst MW. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 2007;26:241-248 DOI ScienceOn |
13 | Mackey TJ, Borkowski A, Amin P, Jacobs SC, Kyprianou N. bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer. Urology 1998;52:1085-1090 DOI PUBMED ScienceOn |
14 | Holl V, Coelho D, Weltin D, Dufour P, Gueulette J, Bischoff P. Ex vivo determination of the effect of whole-body exposure to fast neutrons on murine spleen cell viability and apoptosis. Radiat Res 2000;154:301-306 DOI ScienceOn |
15 | Wang LP, Liang K, Shen Y, Yin WB, Hans G, Zeng YJ. Neutron-induced apoptosis of HR8348 cells in vitro. World J Gastroenterol 2001;7:435-439 DOI PUBMED |
16 | Moeller BJ, Cao Y, Li CY, Dewhirst MW. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors:role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004;5:429-441 DOI ScienceOn |
17 | Wambersie A, Hendry J, Gueulette J, Gahbauer R, Potter R, Gregoire V. Radiobiological rationale and patient selection for high-LET radiation in cancer therapy. Radiother Oncol 2004;73 Suppl 2:S1-14 |
18 | Zhong H, Semenza GL, Simons JW, De Marzo AM. Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detect Prev 2004;28:88-93 DOI ScienceOn |
19 | Moeller BJ, Dreher MR, Rabbani ZN, et al. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 2005;8:99-110 DOI ScienceOn |
20 | Forman JD, Yudelev M, Bolton S, Tekyi-Mensah S, Maughan R. Fast neutron irradiation for prostate cancer. Cancer Metastasis Rev 2002;21:131-135 DOI ScienceOn |
21 | Khor LY, Desilvio M, Li R, et al. Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10. Int J Radiat Oncol Biol Phys 2006;66:25-30 DOI PUBMED ScienceOn |
22 | Hall EJ, Giaccia AJ. Radiobiology for the radiologist. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2006:109 |
23 | Anastasiadis AG, Stisser BC, Ghafar MA, Burchardt M, Buttyan R. Tumor hypoxia and the progression of prostate cancer. Curr Urol Rep 2002;3:222-228 DOI ScienceOn |
24 | Chan N, Milosevic M, Bristow RG. Tumor hypoxia, DNA repair and prostate cancer progression: new targets and new therapies. Future Oncol 2007;3:329-341 DOI ScienceOn |
25 | Semenza GL. Angiogenesis in ischemic and neoplastic disorders. Annu Rev Med 2003;54:17-28 DOI PUBMED ScienceOn |
26 | Khor LY, Moughan J, Al-Saleem T, et al. Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02. Clin Cancer Res 2007;13:3585-3590 DOI ScienceOn |